Patents by Inventor David Sweedler

David Sweedler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030073640
    Abstract: This invention features permeability enhancer molecules, and methods, to increase membrane permeability of various molecules, such as nucleic acids, polynucleotides, oligonucleotides, enzymatic nucleic acid molecules, antisense nucleic acid molecules, 2-5A antisense chimeras, triplex forming oligonucleotides, decoy RNAs, dsRNAs, siRNAs, aptamers, or antisense nucleic acids containing nucleic acid cleaving chemical groups, peptides, polypeptides, proteins, carbohydrates, steroids, metals and small molecules, thereby facilitating cellular uptake of such molecules.
    Type: Application
    Filed: December 21, 2001
    Publication date: April 17, 2003
    Applicant: Ribozyme Pharmaceuticals, Inc.
    Inventors: Leonid Beigelman, Jasenka Matulic-Adamic, Alexander Karpeisky, Peter Haeberli, David Sweedler, Mark Reynolds, Nilabh Chaudhary, John Min
  • Patent number: 6528640
    Abstract: Novel nucleotide triphosphates, methods of synthesis and process of incorporating these nucleotide triphosphates into oligonucleotides, and isolation of novel nucleic acid catalysts (e.g., ribozymes) are disclosed. Also, described are the use of novel enzymatic nucleic acid molecules to inhibit HER2/neu/ErbB2 gene expression and their applications in human therapy.
    Type: Grant
    Filed: December 29, 1999
    Date of Patent: March 4, 2003
    Assignee: Ribozyme Pharmaceuticals, incorporated
    Inventors: Leonid Beigelman, Alex Burgin, Amber Beaudry, Alexander Karpeisky, Jasenka Matulic-Adamic, David Sweedler, Shawn Zinnen
  • Patent number: 6509460
    Abstract: Novel nucleoside triphosphates, methods of synthesis and process of incorporating these nucleoside triphosphates into oligonucleotides are disclosed.
    Type: Grant
    Filed: August 23, 2000
    Date of Patent: January 21, 2003
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Leonid Beigelman, Alex Burgin, Amber Beaudry, Alexander Karpeisky, Jasenka Matulic-Adamic, David Sweedler
  • Publication number: 20030004122
    Abstract: The present invention relates to novel nucleotide triphosphates, methods of synthesis and process of incorporating these nucleotide triphosphates into oligonucleotides, and isolation of novel nucleic acid catalysts (e.g., ribozymes or DNAzymes). Also, provided are the use of novel enzymatic nucleic acid molecules to inhibit HER2/neu/ErbB2 gene expression and their applications in human therapy.
    Type: Application
    Filed: April 4, 2001
    Publication date: January 2, 2003
    Inventors: Leonid Beigelman, Alex Burgin, Amber Beaudry, Alexander Karpeisky, Jasenka Matulic-Adamic, David Sweedler, Shawn Zinnen
  • Patent number: 6482932
    Abstract: Novel nucleotide triphosphates, methods of synthesis and process of incorporating these nucleotide triphosphates into oligonucleotides, and isolation of novel nucleic acid catalysts (e.g., ribozymes) are disclosed.
    Type: Grant
    Filed: April 28, 1999
    Date of Patent: November 19, 2002
    Assignee: Ribozyme Pharmaceuticals, Incorporated
    Inventors: Leonid Beigelman, Alex Burgin, Amber Beaudry, Alexander Karpeisky, Jasenka Matulic-Adamic, David Sweedler, Shawn Zinnen
  • Patent number: 6469158
    Abstract: Method for purification and synthesis of RNA molecules and enzymatic RNA molecules in enzymatically active form.
    Type: Grant
    Filed: May 2, 1995
    Date of Patent: October 22, 2002
    Assignee: Ribozyme Pharmaceuticals, Incorporated
    Inventors: Nassim Usman, Francine Wincott, David Sweedler, Leonid Beigelman, Lech W. Dudycz, Susan Grimm, Anthony DiRenzo, Danuta Tracz
  • Publication number: 20020150936
    Abstract: The present invention provides methods for the chemical synthesis of nucleosides and derivatives thereof, including 2′-amino, 2′-N-phthaloyl, 2′-O-methyl, 2′-O-silyl, 2′-O-triisopropylsilyloxymethyl, 2′-OH nucleosides, C-nucleosides, nucleoside phosphoramidites, C-nucleoside phosphoramidites, and non-nucleoside derivatives.
    Type: Application
    Filed: January 11, 2002
    Publication date: October 17, 2002
    Inventors: Leonid Beigelman, Alexander Karpeisky, Vladmir Serebryany, Peter Haeberli, David Sweedler
  • Publication number: 20020120129
    Abstract: The present invention provides methods for the chemical synthesis of nucleosides and derivatives thereof, including 2′-amino, 2′-N-phthaloyl, 2′-O-methyl, 2′-O-silyl, 2′OH nucleosides, C-nucleosides, nucleoside phosphoramidites, C-nucleoside phosphoramidites, and non-nucleoside derivatives.
    Type: Application
    Filed: August 31, 2001
    Publication date: August 29, 2002
    Inventors: Leonid Beigelman, Alexander Karpeisky, Vladmir Serebryany, Peter Haeberli, David Sweedler
  • Patent number: 6437117
    Abstract: Method for purification and synthesis of RNA molecules and enzymatic RNA molecules in enzymatically active form.
    Type: Grant
    Filed: July 27, 1999
    Date of Patent: August 20, 2002
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Nassim Usman, Francine Wincott, David Sweedler, Leonid Beigelman, Lech W. Dudycz, Susan Grimm, Anthony DiRenzo, Danuta Tracz
  • Patent number: 6395713
    Abstract: This invention features permeability enhancer molecules, and methods, to increase membrane permeability of negatively charged polymers thereby facilitating cellular uptake of such polymers.
    Type: Grant
    Filed: July 21, 1998
    Date of Patent: May 28, 2002
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Leonid Beigelman, Jasenka Matulic-Adamic, Alex Karpeisky, Peter Haeberli, David Sweedler, Mark Reynolds, Nilabh Chaudhary, John Min
  • Patent number: 6127535
    Abstract: Novel nucleoside triphosphates, methods of synthesis and process of incorporating these nucleoside triphosphates into oligonucleotides are disclosed.
    Type: Grant
    Filed: November 4, 1998
    Date of Patent: October 3, 2000
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Leonid Beigelman, Alex Burgin, Amber Beaudry, Alexander Karpeisky, Jasenka Matulic-Adamic, David Sweedler
  • Patent number: 5962675
    Abstract: Several processes for the chemical synthesis of 2'-O-methoxy purine nucleosides are herein disclosed.
    Type: Grant
    Filed: December 23, 1996
    Date of Patent: October 5, 1999
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Leonid Beigelman, David Sweedler, Peter Haeberli, Alexander Karpeisky
  • Patent number: 5631360
    Abstract: A method for blocking the 2'-amino group of a nucleoside phosphoramidite using an N-phthaloyl protecting group. The 2'-amino-N-phthaloyl protected nucleotides are also disclosed.
    Type: Grant
    Filed: May 5, 1995
    Date of Patent: May 20, 1997
    Assignee: Ribozyme Pharmaceuticals, Inc.
    Inventors: Nassim Usman, David Sweedler, Leonid Beigelman